NEUROONE MEDICAL TECHNOLOGIES Corp·4

May 24, 4:03 PM ET

McClurg Ronald W. 4

4 · NEUROONE MEDICAL TECHNOLOGIES Corp · Filed May 24, 2022

Insider Transaction Report

Form 4
Period: 2022-05-20
McClurg Ronald W.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-05-24$0.98/sh+10,500$10,29143,000 total
  • Purchase

    Common Stock

    2022-05-20$0.85/sh+17,500$14,92432,500 total
Footnotes (2)
  • [F1]The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $0.80 to $0.878 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
  • [F2]The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $0.9174 to $1.00 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT